Stock Market & Financial Investment News

News Breaks March 1, 2013 08:04 EDT NVAX Novavax reports Q EPS (6c), consensus (4c) Reports Q4 revenue $4.57M, consensus $7.04M. Reports cash, cash equivalents and investments totaling $50.3M at Dec. 31, 2012, compared to $18.3M at Dec. 31, 2011. News For NVAX From The Last 14 Days Check below for free stories on NVAX the last two weeks. Sign up for a free trial to see the rest of the stories you've been missing. May 20, 2013 08:04 EDT NVAX Flexion Therapeutics names Frederick Driscoll CFO Subscribe for More Information May 10, 2013 08:09 EDT NVAX Novavax H7N9 influenza vaccine enters animal testing Subscribe for More Information Sign up for a free trial to see the rest of the stories you've been missing.